Streetbeat News

Analyst Ratings

RJF

Wells Fargo has initiated coverage on Raymond James Financial with an Overweight rating and set a price target of $138.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:54 pm

IFS

JP Morgan analyst Yuri Fernandes maintains an Overweight rating on Intercorp Financial Services (NYSE:IFS) but lowers the price target from $31 to $30.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:51 pm

KIRK

Benchmark analyst John Lawrence has reiterated a Buy rating on Kirkland's (NASDAQ:KIRK) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:51 pm

LKQ

JP Morgan analyst Samik Chatterjee maintains an Overweight rating on LKQ and raises the price target from $54 to $55.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:49 pm

POET

Craig-Hallum analyst Richard Shannon maintains a Buy rating on POET Technologies and raises the price target from $3 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:48 pm

NI

BMO Capital has maintained its 'Outperform' rating on NiSource and raised the price target from $34 to $36, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:46 pm

SRE

BMO Capital analyst James Thalacker maintains an Outperform rating on Sempra (NYSE:SRE) and raises the price target from $90 to $93.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:44 pm

CVS

ET

HD

PLTR

PYPL

RIVN

Jim Cramer recommends buying PayPal due to its expanded partnership with Shopify. He advises patience with Rivian, despite its financial stability. Cramer is cautious about CVS Health and sees potential in Energy Transfer and The Home Depot. Palantir is noted for its S&P 500 inclusion.

Portfolio Pulse from Avi Kapoor

September 12, 2024 | 12:41 pm

GLUE

Wedbush analyst Robert Driscoll has reiterated an Outperform rating for Monte Rosa Therapeutics (NASDAQ:GLUE) and maintained a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:40 pm

KBH

Wedbush analyst Jay McCanless has reiterated a Neutral rating on KB Home (NYSE:KBH) and maintained a price target of $67.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:38 pm